Search This Blog

Thursday, February 27, 2020

Allogene Therapeutics EPS beats by $0.12

Allogene Therapeutics (NASDAQ:ALLO): Q4 GAAP EPS of -$0.58 beats by $0.12.
Cash, cash equivalents, and investments of $588.9M.
Press Release
https://seekingalpha.com/news/3546294-allogene-therapeutics-eps-beats-0_12
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)